• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型咪唑取代二肽酰胺的设计与合成:作为白色念珠菌肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的强效和选择性抑制剂以及具有基于机制的抗真菌活性的相关三肽抑制剂的鉴定

Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.

作者信息

Devadas B, Freeman S K, Zupec M E, Lu H F, Nagarajan S R, Kishore N S, Lodge J K, Kuneman D W, McWherter C A, Vinjamoori D V, Getman D P, Gordon J I, Sikorski J A

机构信息

Department of Medicinal and Structural Chemistry, G.D. Searle and Company, St. Louis, Missouri 63198, USA.

出版信息

J Med Chem. 1997 Aug 1;40(16):2609-25. doi: 10.1021/jm970094w.

DOI:10.1021/jm970094w
PMID:9258368
Abstract

A new class of antifungal agents has been discovered which exert their activity by blockade of myristoylCoA: protein N-myristoyltransferase (NMT; EC 2.1.3.97). Genetic experiments have established that NMT is needed to maintain the viability of Candida albicans and Cryptococcus neoformans,the two principal causes of systemic fungal infections in immunocompromised humans. Beginning with a weak octapeptide inhibitor ALYASKLS-NH2 (2, Ki = 15.3 +/- 6.4 microM), a series of imidazole-substituted Ser-Lys dipeptide amides have been designed and synthesized as potent and selective inhibitors of Candida albicans NMT. The strategy that led to these inhibitors evolved from the identification of those functional groups in the high-affinity octapeptide substrate GLYASKLS-NH2 1a necessary for tight binding, truncation of the C-terminus, replacement of the four amino acids at the N-terminus by a spacer group, and substitution of the glycine amino group with an N-linked 2-methylimidazole moiety. Initial structure-activity studies led to the identification of 31 as a potent and selective peptidomimetic inhibitor with an IC50 of 56 nM and 250-fold selectivity versus human NMT. 2-Methylimidazole as the N-terminal amine replacement in combination with a 4-substituted phenacetyl moiety imparts remarkable potency and selectivity to this novel class of inhibitors. The (S,S) stereochemistry of serine and lysine residues is critical for the inhibitory activity, since the (R,R) enantiomer 40 is 10(3)-fold less active than the (S,S) isomer 31. The inhibitory profile exhibited by this new class of NMT ligands is a function of the pKa of the imidazole substituent as illustrated by the benzimidazole analog 35 which is about 10-fold less potent than 31. The measured pKa (7.1 +/- 0.5) of 2-methylimidazole in 31 is comparable with the estimated pKa (approximately 8.0) of the glycyl residue in the high-affinity substrate 1a. Groups bulkier than methyl, such as ethyl, isopropyl, or iodo, at the imidazole 2-position have a detrimental effect on potency. Further refinement of 31 by grafting an alpha-methyl group at the benzylic position adjacent to the serine residue led to 61 with an IC50 of 40 nM. Subsequent chiral chromatography of 61 culminated in the discovery of the most potent Candida NMT inhibitor 61a reported to date with an IC50 of 20 nM and 400-fold selectivity versus the human enzyme. Both 31 and 61a are competitive inhibitors of Candida NMT with respect to the octapeptide substrate GNAASARR-NH2 with Ki(app) = 30 and 27 nM, respectively. The potency and selectivity displayed by these inhibitors are dependent upon the size and orientation of the alpha-substituent. An alpha-methyl group with the R configuration corresponding to the (S)-methyl-4-alanine in 2 confers maximum potency and selectivity. Structural modification of 31 and 61 by appending an (S)-carboxyl group beta to the cyclohexyl moiety provided the less potent tripeptide inhibitors 73a and 73b with an IC50 of 1.45 +/- 0.08 and 0.38 +/- 0.03 microM, respectively. However, these tripeptides (73a and 73b) exhibited a pronounced selectivity of 560- and 2200-fold versus the human NMT. More importantly 73a displayed fungistatic activity against C albicans with an EC50 of 51 +/- 17 microM in cell culture. Compound 73b also exhibited a similar antifungal activity. An Arf protein gel mobility shift assay for monitoring intracellular myristoylation revealed that a single dose of 200 microM of 73a or 73b produced < 50% reduction in Arf N-myristoylation, after 24 and 48 h, consistent with their fungistatic rather than fungicidal activity. In contrast, the enantiomer 73d which had an IC50 > 1000 microM against C. albicans NMT did not exhibit antifungal activity and produced no detectable reduction in Arf N-myristoylation in cultures of C. albicans. These studies confirm that the observed antifungal activity of 73a and 73b is due to the attenuation of NMT activity and that NMT represents an attractive tar

摘要

已发现一类新型抗真菌剂,它们通过阻断肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶(NMT;EC 2.1.3.97)发挥其活性。遗传学实验已证实,NMT是维持白色念珠菌和新型隐球菌生存能力所必需的,这两种菌是免疫功能低下人群系统性真菌感染的两个主要病因。从弱八肽抑制剂ALYASKLS-NH2(2,Ki = 15.3±6.4 microM)开始,设计并合成了一系列咪唑取代的丝氨酸-赖氨酸二肽酰胺,作为白色念珠菌NMT的强效和选择性抑制剂。导致这些抑制剂的策略源于对高亲和力八肽底物GLYASKLS-NH2 1a中紧密结合所必需的那些官能团的鉴定,C端截短,用间隔基团取代N端的四个氨基酸,以及用N-连接的2-甲基咪唑部分取代甘氨酸氨基。初步的构效关系研究导致鉴定出31作为一种强效和选择性拟肽抑制剂,其IC50为56 nM,对人NMT的选择性为250倍。2-甲基咪唑作为N端胺取代基与4-取代苯乙酰部分相结合,赋予了这类新型抑制剂显著的效力和选择性。丝氨酸和赖氨酸残基的(S,S)立体化学对抑制活性至关重要,因为(R,R)对映体40的活性比(S,S)异构体31低10³倍。这类新型NMT配体表现出的抑制特征是咪唑取代基pKa的函数,如苯并咪唑类似物35所示,其效力比31低约10倍。31中2-甲基咪唑的实测pKa(7.1±0.5)与高亲和力底物1a中甘氨酰残基的估计pKa(约8.0)相当。咪唑2位上比甲基更大的基团,如乙基、异丙基或碘,对效力有不利影响。通过在与丝氨酸残基相邻的苄基位置接上一个α-甲基对31进行进一步优化,得到了IC50为40 nM的61。随后对61进行手性色谱分离,最终发现了迄今为止报道的最有效的白色念珠菌NMT抑制剂61a,其IC50为20 nM,对人酶的选择性为400倍。31和61a都是白色念珠菌NMT相对于八肽底物GNAASARR-NH2的竞争性抑制剂,Ki(app)分别为30和27 nM。这些抑制剂表现出的效力和选择性取决于α-取代基的大小和取向。与2中(S)-甲基-4-丙氨酸对应的具有R构型的α-甲基赋予最大的效力和选择性。通过在环己基部分β位接上一个(S)-羧基对31和61进行结构修饰,得到了效力较低的三肽抑制剂73a和73b,其IC50分别为1.45±0.08和0.38±0.03 microM。然而,这些三肽(73a和73b)对人NMT表现出560倍和2200倍的显著选择性。更重要的是,73a在细胞培养中对白色念珠菌表现出抑菌活性,EC50为51±17 microM。化合物73b也表现出类似的抗真菌活性。用于监测细胞内肉豆蔻酰化的Arf蛋白凝胶迁移率变动分析表明,单剂量200 microM的73a或73b在24和48小时后使Arf N-肉豆蔻酰化降低<50%,这与其抑菌而非杀菌活性一致。相比之下,对白色念珠菌NMT的IC50>1000 microM的对映体73d在白色念珠菌培养物中未表现出抗真菌活性,也未使Arf N-肉豆蔻酰化出现可检测到的降低。这些研究证实,观察到的73a和73b的抗真菌活性是由于NMT活性的减弱,并且NMT是一个有吸引力的靶点。

相似文献

1
Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.新型咪唑取代二肽酰胺的设计与合成:作为白色念珠菌肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的强效和选择性抑制剂以及具有基于机制的抗真菌活性的相关三肽抑制剂的鉴定
J Med Chem. 1997 Aug 1;40(16):2609-25. doi: 10.1021/jm970094w.
2
Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.白色念珠菌肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的选择性肽类和拟肽类抑制剂:抗真菌治疗的新方法
Biopolymers. 1997;43(1):43-71. doi: 10.1002/(SICI)1097-0282(1997)43:1<43::AID-BIP5>3.0.CO;2-0.
3
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.构象受限的[p-(ω-氨基烷基)苯乙酰基]-L-丝氨酰-L-赖氨酰二肽酰胺作为白色念珠菌和人肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的有效拟肽抑制剂。
J Med Chem. 1997 May 9;40(10):1422-38. doi: 10.1021/jm9608671.
4
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.新型肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的生物活性非肽类抑制剂。
J Med Chem. 1998 Mar 12;41(6):996-1000. doi: 10.1021/jm980001q.
5
N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.白色念珠菌中Arf蛋白的N-肉豆蔻酰化:一种用于评估肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶抗真菌抑制剂的体内试验。
Microbiology (Reading). 1997 Feb;143 ( Pt 2):357-366. doi: 10.1099/00221287-143-2-357.
6
Scanning alanine mutagenesis and de-peptidization of a Candida albicans myristoyl-CoA:protein N-myristoyltransferase octapeptide substrate reveals three elements critical for molecular recognition.白色念珠菌肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶八肽底物的扫描丙氨酸诱变和去肽化揭示了分子识别的三个关键元件。
J Biol Chem. 1997 May 2;272(18):11874-80. doi: 10.1074/jbc.272.18.11874.
7
Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.苯并杂环 N-豆蔻酰基转移酶抑制剂的等排类似物的设计、合成与抗真菌活性。
Eur J Med Chem. 2010 Sep;45(9):3531-40. doi: 10.1016/j.ejmech.2010.03.007. Epub 2010 Mar 12.
8
Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure.基于苯并噻唑结构的白色念珠菌N-肉豆蔻酰转移酶强效和选择性抑制剂的合成
Bioorg Med Chem. 2005 Apr 1;13(7):2509-22. doi: 10.1016/j.bmc.2005.01.033.
9
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.新型强效且具选择性的基于底物的p60c-src蛋白酪氨酸激酶抑制剂系列的发现:肽设计中的构象和拓扑限制
J Med Chem. 1998 Jun 18;41(13):2252-60. doi: 10.1021/jm9707885.
10
Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.作为Src SH2结构域抑制剂的四肽配体设计
Bioorg Med Chem. 2004 Feb 15;12(4):779-87. doi: 10.1016/j.bmc.2003.10.060.

引用本文的文献

1
Discovery of Novel Myristic Acid Derivatives as N-Myristoyltransferase Inhibitors: Design, Synthesis, Analysis, Computational Studies and Antifungal Activity.新型肉豆蔻酸衍生物作为N-肉豆蔻酰基转移酶抑制剂的发现:设计、合成、分析、计算研究及抗真菌活性
Antibiotics (Basel). 2023 Jul 9;12(7):1167. doi: 10.3390/antibiotics12071167.
2
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.一种分子杂交方法设计强效、高选择性、可穿透血脑屏障的 N-豆蔻酰转移酶抑制剂。
J Med Chem. 2018 Sep 27;61(18):8374-8389. doi: 10.1021/acs.jmedchem.8b00884. Epub 2018 Sep 12.
3
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.
蛋白质脂化:发生、机制、生物功能和使能技术。
Chem Rev. 2018 Feb 14;118(3):919-988. doi: 10.1021/acs.chemrev.6b00750. Epub 2018 Jan 2.
4
The N-myristoylome of Trypanosoma cruzi.克氏锥虫的N-肉豆蔻酰化蛋白质组
Sci Rep. 2016 Aug 5;6:31078. doi: 10.1038/srep31078.
5
Design, Synthesis and Antifungal Activity of Novel Benzofuran-Triazole Hybrids.新型苯并呋喃-三唑杂化物的设计、合成及抗真菌活性
Molecules. 2016 Jun 7;21(6):732. doi: 10.3390/molecules21060732.
6
N-myristoyltransferase is a cell wall target in Aspergillus fumigatus.N-肉豆蔻酰转移酶是烟曲霉细胞壁的一个靶点。
ACS Chem Biol. 2015 Jun 19;10(6):1425-34. doi: 10.1021/cb5008647. Epub 2015 Feb 27.
7
Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.恶性疟原虫N-肉豆蔻酰转移酶的同源建模与分子动力学模拟:对新型抗疟药物设计的见解
J Mol Model. 2015 Mar;21(3):37. doi: 10.1007/s00894-015-2586-4. Epub 2015 Feb 7.
8
Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.来自人类疟疾和利什曼病寄生虫的N-肉豆蔻酰转移酶的拟肽抑制剂。
Org Biomol Chem. 2014 Nov 7;12(41):8132-7. doi: 10.1039/c4ob01669f. Epub 2014 Sep 18.
9
Drug discovery for neglected diseases: molecular target-based and phenotypic approaches.治疗被忽视疾病的药物研发:基于分子靶标和表型的方法。
J Med Chem. 2013 Oct 24;56(20):7719-26. doi: 10.1021/jm400362b. Epub 2013 Sep 9.
10
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.设计和合成恶性疟原虫 N-豆蔻酰转移酶抑制剂,这是抗疟药物发现的一个有前途的靶点。
J Med Chem. 2012 Oct 25;55(20):8879-90. doi: 10.1021/jm301160h. Epub 2012 Oct 15.